Related Drugs Ajovy Amerge Axert Cataflam Elyxyb Emgality Fioricet Frova Imitrex Imitrex Injection Imitrex Nasal Spray Maxalt Migergot Nurtec ODT Onzetra Xsail Reyvow Tosymra Trianal Vyepti Zomig Zomig Nasal Spray; Examples include anti-Check all prescription and nonprescription medicine labels carefully since many medications contain pain relievers/fever reducers (This medication may interfere with certain laboratory tests (including bleeding times, adrenal function tests), possibly causing false test results. 500 mg for 1 dose, to be taken in combination with sumatriptan as soon as migraine symptoms develop. Adults—1000 to 1500 milligrams (mg) (taken as two to three 500 mg tablets) once a day for the first dose, then 1000 mg (taken as two 500 mg tablets) once a day until the attack is relieved. Swallow the tablet whole. Select one or more newsletters to continue. Naproxen is statistically superior to placebo in the treatment of acute migraine, but the NNT of 11 for pain-free response at two hours suggests that it is not a clinically useful treatment. Our general interest e-newsletter keeps you up to date on a wide variety of health topics.Use this medicine only as directed by your doctor. For oral dosage form (tablets): For migraine headaches: Adults—One tablet once a day.
If there is no improvement in your symptoms, do not take more doses of this medication before talking to your doctor. sumatriptan 85 mg-naproxen 500 mg tablet. The dose of this medicine will be different for different patients.
Learn about dosage, uses, side effects, and more. This medicine often relieves other symptoms that occur together with a migraine headache, such as nausea, vomiting, sensitivity to light, and sensitivity to sound.
Use the lowest dose that is effective in treating your condition. Naproxen-sumatriptan 500 mg-85 mg 658620928. capsule, white, imprinted with J78. To treat migraine with Imitrex nasal spray, your doctor may prescribe a dose of 5 mg, 10 mg, or 20 mg. To take a dose of 10 mg, you’ll use two 5 mg sprays (one in each nostril). Available for Android and iOS devices. The most effective dose of oral sumatriptan is 100 mg, while the 50 mg dose may provide the best combination of efficacy and tolerability . Make sure laboratory personnel and all your doctors know you use this drug.If someone has overdosed and has serious symptoms such as passing out or Store in the original container at room temperature away from light and moisture. Do not store in the bathroom. © 1998-2020 Mayo Foundation for Medical Education and Research (MFMER). They may contain ingredients similar to naproxen (such as aspirin, Stop taking this medicine and seek emergency medical help if you have Stop using this medicine and call your doctor at once if you have:numbness, tingling, pale or blue-colored appearance in your fingers or toes;leg cramps, burning, coldness, or heavy feeling in your feet or legs;severe headache, blurred vision, pounding in your neck or ears;heart problems--swelling, rapid weight gain, feeling short of breath;kidney problems--little or no urination, swelling in your feet or ankles, feeling tired or short of breath;liver problems--loss of appetite, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, low red blood cells (anemia)--pale skin, unusual tiredness, feeling light-headed or short of breath;signs of stomach bleeding--bloody or tarry stools, stomach problems--sudden severe stomach pain (especially after eating), vomiting, tight muscles, pain or pressure in your chest or throat.This is not a complete list of side effects and others may occur. Properly discard this product when it is expired or no longer needed. Children 12 to 17 years of age—One tablet once a day. You may report side effects to Health Canada at 1-866-234-2345.This drug may make you dizzy or drowsy. An aura is a strange feeling or visual disturbance that warns you of an attack. Talk to your doctor about what to do for regular headaches. Do not take more than 1 tablet in 24 hours. All material on this website is protected by copyright, Copyright © 1994-2020 by WebMD LLC. If your dose is different, do not change it unless your doctor tells you to do so.The amount of medicine that you take depends on the strength of the medicine. Do not use more of it and do not use it more often than directed.
For adults: If your headache does not improve after taking this medicine, wait at least 2 hours before taking a second dose. Safety of treating an average of >2 migraine headaches in pediatric patients in a 30-day period has not been established Limit your time in the sun. NAPROXEN; SUMATRIPTAN is used to treat migraines with or without aura. /viewarticle/934908 It comes as a tablet. 6 mg (0.5 mL) SC with autoinjector; may repeat in ≥1 hourMild to moderate hepatic impairment: Oral not to exceed 50 mg/dose; no dosage adjustments necessary if administered SC (use with caution)Use not recommended (higher incidence of adverse effects)MI and coronary artery vasospasm in patients with CAD risk factors (extremely rare)Current/history of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes (angina, MI, stroke, TIA, ischemic bowel disease)History of stroke, transient ischemic attack, or hemiplegic or basilar migraineHistory of coronary artery disease or coronary artery vasospasmWolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disordersWithin 24 hours of another 5-HT1 receptor agonist or ergot-type medicationsBefore treating headaches in patients not previously diagnosed with migraine or cluster headache or in patients who present with atypical symptoms, exclude other potentially serious neurological conditionsEqually effective at any stage of migraine, although early use recommendedOveruse of acute migraine drugs (eg, ergotamine, triptans, opioids, or combination of these drugs for ≥10 days/month) may lead to exacerbation of headache (medication overuse headache); detoxification may be necessaryBinds to melanin, may cause toxicity to melanin-rich tissues on prolonged useVery rare reports of transient and permanent blindness and significant partial vision lossSerotonin syndrome may occur, particularly during combined use with SSRIs (eg, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram) or SNRIs (eg, venlafaxine, duloxetine); discontinue therapy if it occursCerebral/subarachnoid hemorrhage and stroke reported with 5-HT1 agonist administration; discontinue if it occursSignificant elevation of blood pressure, including hypertensive crisis, reportedNot for administration to patients with risk factors for coronary artery diseaseUse caution in patients with history of seizure disorder or lowered seizure thresholdMay cause depression including dizziness, weakness, or drowsiness (infrequent); caution when operating heavy machineryCoronary artery vasospasm, transient ischemia, ventricular tachycardia/fibrillation, myocardial infarction, cardiac arrest and death reported with use 5HT1 agonists; perform cardiac evaluation in patients with multiple cardiovascular risk factors; evaluate for coronary artery disease in patients at high risk; discontinue therapy if arrhythmia occursUse oral formulations with caution in patients with mild-to-moderate hepatic impairment if treatment necessary and advisable; presystemic clearance, when administered orally, is reduced in hepatic impairment and cause an increase in plasma concentrations; dose reduction recommended; when adminsitered parenterally (SC, intranasal), does not undergo first pass metabolism and may not cause increase in plasma concentrationsHypersensitivity reactions, including angioedema and anaphylaxis, reported; needle shield of prefilled syringe contains dry natural rubber (a latex derivative) that has potential to cause allergic reactions in latex-sensitive individualsData from a prospective pregnancy exposure registry and epidemiological studies of pregnant women have not detected increased frequency of birth defects or consistent pattern of birth defects among women exposed to sumatriptan compared with general population; in developmental toxicity studies in rats and rabbits, oral administration of sumatriptan to pregnant animals was associated with embryolethality, fetal abnormalities, and pup mortality; when administered by intravenous route to pregnant rabbits, sumatriptan was embryolethalHowever, possible disease-associated maternal and/or embryo/fetal risk reported; several studies have suggested that women with migraine may be at increased risk of preeclampsia during pregnancySumatriptan is excreted in human milk following subcutaneous administration; there are no data on effects of sumatriptan on breastfed infant or effects of sumatriptan on milk production; developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for injection and any potential adverse effects on breastfed infant from sumatriptan or from underlying maternal conditionInfant exposure to sumatriptan can be minimized by avoiding breastfeeding for 12 hr after therapyA: Generally acceptable.